BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 36455598)

  • 1. Investigating protease-mediated peptides of inflammation and tissue remodeling as biomarkers associated with flares in psoriatic arthritis.
    Groen SS; Nielsen SH; Bay-Jensen AC; Rasti M; Ganatra D; Oikonomopoulou K; Chandran V
    Arthritis Res Ther; 2024 May; 26(1):107. PubMed ID: 38802975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
    Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
    RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study.
    Dobrota R; Jordan S; Juhl P; Maurer B; Wildi L; Bay-Jensen AC; Karsdal MA; Herrick AL; Distler JHW; Allanore Y; Hoffmann-Vold AM; Siebuhr AS; Distler O
    Lancet Rheumatol; 2021 Mar; 3(3):e175-e184. PubMed ID: 38279380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neo-epitope detection identifies extracellular matrix turnover in systemic inflammation and sepsis: an exploratory study.
    Fan Y; Moser J; van Meurs M; Kiers D; Sand JMB; Leeming DJ; Pickkers P; Burgess JK; Kox M; Pillay J
    Crit Care; 2024 Apr; 28(1):120. PubMed ID: 38609959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Extracellular Matrix Molecules and Their Fragments as Biomarkers of Inflammation and Fibrosis in Inflammatory Bowel Diseases - A Systematic Review.
    Poulsen A; Ovesen PD; Lu C; Bettenworth D; Jairath V; Feagan BG; Seidelin JB; Rieder F
    J Crohns Colitis; 2024 May; ():. PubMed ID: 38758527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease.
    Karsdal MA; Hallsworth K; Scragg J; Leeming DJ; Villesen IF; Avery L; Haigh L; Govaere O; Wichmann S; Taylor G; Cassidy S; McPherson S; Anstee QM
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37756043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-glycan signatures identified in the serum from biliary tract cancer patients: Association with clinical diagnosis and prognosis.
    Huang C; Qiu Z; Wang M; Ji J; Xiao X; Wang Y; Xu X; Gao Z; Gao C
    J Hepatobiliary Pancreat Sci; 2024 Jun; ():. PubMed ID: 38824438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
    Hasselbalch HC; Junker P; Skov V; Kjær L; Knudsen TA; Larsen MK; Holmström MO; Andersen MH; Jensen C; Karsdal MA; Willumsen N
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment-derived serum markers as a new frontier of diagnostic and prognostic assessment in biliary tract cancers.
    Désert R; Giannone F; Schuster C; Baumert TF
    Int J Cancer; 2023 Mar; 152(5):804-806. PubMed ID: 36455586
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients.
    Jensen C; Madsen DH; Hansen M; Schmidt H; Svane IM; Karsdal MA; Willumsen N
    J Immunother Cancer; 2018 Dec; 6(1):152. PubMed ID: 30567561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile liquid biopsy in biliary tract cancer.
    Liu F; Hao X; Liu B; Liu S; Yuan Y
    Clin Chim Acta; 2023 Nov; 551():117593. PubMed ID: 37839517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
    Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
    Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma.
    Hurkmans DP; Jensen C; Koolen SLW; Aerts J; Karsdal MA; Mathijssen RHJ; Willumsen N
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33093157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.